FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202551131> ?p ?o ?g. }

• W3202551131 endingPage "1302" @default.
• W3202551131 startingPage "1291" @default.
• W3202551131 abstract "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have represented the prototype of targeted therapy in NSCLC. Patients with EGFR-mutant lung adenocarcinoma extract an extraordinary clinical benefit from EGFR-TKIs. However, the extent and duration of these responses are heterogeneous, suggesting the existence of genetic modifiers affecting an individual's response to TKIs. We investigated whether genetic variants in miRNA binding sites are associated with the clinical outcome of EGFR-TKIs in lung adenocarcinoma patients.One hundred SNPs at miRNA binding sites in cancer-related genes were selected for the analysis using the crosslinking, ligation and sequencing of hybrids (CLASH) and CancerGenes database. qRT-PCR and luciferase assays were conducted to evaluate the functional relevance of the SNPs.NUP62 rs9523A>G were significantly associated with worse response to EGFR-TKIs, overall survival (OS), and progression-free survival (PFS). The other three SNPs (DVL2 rs2074216G>A, ARF1 rs11541557G>T, and UHRF1 rs2261988C>A) were significantly associated with worse OS and PFS. The rs9523A>G was significantly associated with decreased NUP62 expression in tumor tissues. In addition, a significantly decreased luciferase activity was noted in NUP62 rs9523 G allele compared to A allele.Genetic variants in miRNA binding sites, especially NUP62 rs9523A>G, may be useful in predicting the clinical outcomes of EGFR-mutant lung adenocarcinoma patients treated with EGFR-TKIs." @default.
• W3202551131 created "2021-10-11" @default.
• W3202551131 creator A5006227181 @default.
• W3202551131 creator A5007488043 @default.
• W3202551131 creator A5008078972 @default.
• W3202551131 creator A5011900177 @default.
• W3202551131 creator A5012086701 @default.
• W3202551131 creator A5012114276 @default.
• W3202551131 creator A5012863258 @default.
• W3202551131 creator A5030593586 @default.
• W3202551131 creator A5032172727 @default.
• W3202551131 creator A5038460242 @default.
• W3202551131 creator A5039670861 @default.
• W3202551131 creator A5047290635 @default.
• W3202551131 creator A5048502103 @default.
• W3202551131 creator A5048830775 @default.
• W3202551131 creator A5063823690 @default.
• W3202551131 creator A5064081097 @default.
• W3202551131 creator A5069522652 @default.
• W3202551131 creator A5070267071 @default.
• W3202551131 date "2021-10-01" @default.
• W3202551131 modified "2023-10-16" @default.
• W3202551131 title "Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients" @default.
• W3202551131 cites W144423133 @default.
• W3202551131 cites W1648301895 @default.
• W3202551131 cites W169584480 @default.
• W3202551131 cites W1980497534 @default.
• W3202551131 cites W1989193114 @default.
• W3202551131 cites W1998971866 @default.
• W3202551131 cites W2002995168 @default.
• W3202551131 cites W2003984225 @default.
• W3202551131 cites W2019607817 @default.
• W3202551131 cites W2024587723 @default.
• W3202551131 cites W2032550506 @default.
• W3202551131 cites W2044151404 @default.
• W3202551131 cites W2069540737 @default.
• W3202551131 cites W2088140119 @default.
• W3202551131 cites W2091134276 @default.
• W3202551131 cites W2096198395 @default.
• W3202551131 cites W2098395191 @default.
• W3202551131 cites W2111234709 @default.
• W3202551131 cites W2111662961 @default.
• W3202551131 cites W2112192177 @default.
• W3202551131 cites W2112602910 @default.
• W3202551131 cites W2116075954 @default.
• W3202551131 cites W2121260558 @default.
• W3202551131 cites W2131323155 @default.
• W3202551131 cites W2132157071 @default.
• W3202551131 cites W2133488997 @default.
• W3202551131 cites W2145173401 @default.
• W3202551131 cites W2146420335 @default.
• W3202551131 cites W2150395782 @default.
• W3202551131 cites W2153436559 @default.
• W3202551131 cites W2162425895 @default.
• W3202551131 cites W2166084034 @default.
• W3202551131 cites W2167398987 @default.
• W3202551131 cites W2171139285 @default.
• W3202551131 cites W2197744034 @default.
• W3202551131 cites W2290213112 @default.
• W3202551131 cites W2526843003 @default.
• W3202551131 cites W2559748686 @default.
• W3202551131 cites W2560717039 @default.
• W3202551131 cites W2597632520 @default.
• W3202551131 cites W2773797060 @default.
• W3202551131 cites W3115045672 @default.
• W3202551131 doi "https://doi.org/10.2147/pgpm.s329055" @default.
• W3202551131 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8493114" @default.
• W3202551131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34629889" @default.
• W3202551131 hasPublicationYear "2021" @default.
• W3202551131 type Work @default.
• W3202551131 sameAs 3202551131 @default.
• W3202551131 citedByCount "0" @default.
• W3202551131 crossrefType "journal-article" @default.
• W3202551131 hasAuthorship W3202551131A5006227181 @default.
• W3202551131 hasAuthorship W3202551131A5007488043 @default.
• W3202551131 hasAuthorship W3202551131A5008078972 @default.
• W3202551131 hasAuthorship W3202551131A5011900177 @default.
• W3202551131 hasAuthorship W3202551131A5012086701 @default.
• W3202551131 hasAuthorship W3202551131A5012114276 @default.
• W3202551131 hasAuthorship W3202551131A5012863258 @default.
• W3202551131 hasAuthorship W3202551131A5030593586 @default.
• W3202551131 hasAuthorship W3202551131A5032172727 @default.
• W3202551131 hasAuthorship W3202551131A5038460242 @default.
• W3202551131 hasAuthorship W3202551131A5039670861 @default.
• W3202551131 hasAuthorship W3202551131A5047290635 @default.
• W3202551131 hasAuthorship W3202551131A5048502103 @default.
• W3202551131 hasAuthorship W3202551131A5048830775 @default.
• W3202551131 hasAuthorship W3202551131A5063823690 @default.
• W3202551131 hasAuthorship W3202551131A5064081097 @default.
• W3202551131 hasAuthorship W3202551131A5069522652 @default.
• W3202551131 hasAuthorship W3202551131A5070267071 @default.
• W3202551131 hasBestOaLocation W32025511311 @default.
• W3202551131 hasConcept C104317684 @default.
• W3202551131 hasConcept C121608353 @default.
• W3202551131 hasConcept C126322002 @default.
• W3202551131 hasConcept C135763542 @default.
• W3202551131 hasConcept C143998085 @default.
• W3202551131 hasConcept C153209595 @default.

• next